Suppr超能文献

胃轻瘫行幽门成形术后结局良好的预测因素:幽门扩张或肉毒杆菌素注射的反应是否可作为手术结局的标志物?

Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?

机构信息

Esophageal Institute, Allegheny Health Network, 4815 Liberty Avenue, Suite 439, Pittsburgh, PA, 15224, USA.

Department of Surgery, Drexel University, Philadephia, PA, USA.

出版信息

Surg Endosc. 2023 Jun;37(6):4360-4369. doi: 10.1007/s00464-023-09882-2. Epub 2023 Feb 7.

Abstract

INTRODUCTION

Pyloroplasty and gastric peroral endoscopic myotomy (G-POEM) are effective surgeries for gastroparesis. The primary aim of this study was to evaluate outcomes of pyloroplasty and G-POEM in patients with gastroparesis and determine factors associated with favorable outcome. The secondary aim was to assess the utility of clinical response to preoperative pyloric dilation or botulinum toxin injection (Botox) on surgical outcome, a factor conventionally used as a favorable marker.

METHODS

There were 204 patients who underwent pyloroplasty (n = 177) or G-POEM (n = 27) for gastroparesis at our institution from 2014 to 2021. Demographic and clinical parameters were analyzed to assess their impact on surgical outcome. A subgroup of patients who had pyloric dilation or Botox injection were assessed separately. Favorable outcome was defined as patient reported complete resolution of the predominant gastroparesis symptom.

RESULTS

Favorable outcome was achieved in 78.4% of patients (pyloroplasty: 79.7% and G-POEM: 70.4%, p = 0.274). Among 61 patients where pre- and postoperative gastric emptying studies (GES) were available, mean 4-hour retention significantly improved from 33.5 to 15.0% (p < 0.001) and 77.0% of patients achieved normalization. Favorable outcome was not significantly impacted by etiology of gastroparesis (p = 0.120), GERD (p = 0.518), or primary gastroparesis symptom (p = 0.244). Age ≥ 40 was a significant predictor of favorable surgical outcome on multivariate analysis [OR: 2.476 (1.224-5.008), p = 0.012]. Among the patients who had preoperative dilation (n = 82) or Botox injection (n = 46), response to these interventions was not a predictor of favorable surgical outcome (p = 0.192 and 0.979, respectively). However, preoperative Botox injection, regardless of response to injection, was associated with favorable surgical outcome [OR: 3.205 (CI 1.105-9.299), p = 0.032].

CONCLUSION

Symptomatic improvement after pyloroplasty or G-POEM is independent of etiology of gastroparesis, GERD, and primary symptom. Response to dilation or Botox are not markers of response to surgery. However, patients who receive Botox are 3.2 times more likely to improve postoperatively.

摘要

简介

幽门成形术和胃经口内镜肌切开术(G-POEM)是治疗胃轻瘫的有效手术。本研究的主要目的是评估胃轻瘫患者接受幽门成形术和 G-POEM 的治疗结果,并确定与良好结果相关的因素。次要目的是评估术前幽门扩张或肉毒杆菌毒素注射(Botox)对手术结果的临床反应的效用,这是传统上用作有利标志物的因素。

方法

本研究纳入了 2014 年至 2021 年期间在我院接受幽门成形术(n=177)或 G-POEM(n=27)治疗的 204 例胃轻瘫患者。分析了人口统计学和临床参数,以评估它们对手术结果的影响。对接受幽门扩张或 Botox 注射的患者进行了亚组评估。良好的结果定义为患者报告主要胃轻瘫症状完全缓解。

结果

78.4%的患者(幽门成形术:79.7%,G-POEM:70.4%,p=0.274)取得了良好的结果。在 61 例可获得术前和术后胃排空研究(GES)的患者中,4 小时胃残留量平均值从 33.5%显著改善至 15.0%(p<0.001),且 77.0%的患者恢复正常。胃轻瘫的病因(p=0.120)、胃食管反流病(p=0.518)或原发性胃轻瘫症状(p=0.244)对手术结果无显著影响。多变量分析显示,年龄≥40 岁是良好手术结果的显著预测因素[比值比:2.476(1.224-5.008),p=0.012]。在接受术前扩张术(n=82)或 Botox 注射(n=46)的患者中,这些干预措施的反应并不能预测手术结果的好坏(p=0.192 和 0.979)。然而,术前 Botox 注射,无论对注射的反应如何,都与良好的手术结果相关[比值比:3.205(CI 1.105-9.299),p=0.032]。

结论

幽门成形术或 G-POEM 后的症状改善与胃轻瘫的病因、胃食管反流病和主要症状无关。扩张或 Botox 的反应不是对手术反应的标志物。然而,接受 Botox 治疗的患者术后改善的可能性增加 3.2 倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b66/10234860/9188e0882f7a/464_2023_9882_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验